---
figid: PMC9251145__ECAM2022-8400496.007
pmcid: PMC9251145
image_filename: ECAM2022-8400496.007.jpg
figure_link: /pmc/articles/PMC9251145/figure/fig7/
number: Figure 7
figure_title: ''
caption: 'Effect of Sal B or TAK-242 in the levels of TLR4, NLRP3, ASC, Caspase-1,
  p-NF-κB, IL-18, IL-1β, and TNF-α proteins induced by iopromide. (a) Sal B reduced
  the levels of p-NF-κB, IL-18, IL-1β, and TNF-α n = 3. Data are the mean ± SD. ∗∗P
  < 0.01 vs. control group; #P < 0.05, ##P < 0.01 vs. iopromide group. (b) Sal B decreased
  the levels of TLR4, NLRP3, ASC, and Caspase-1; n = 3. Data are the mean ± SD. ∗P
  < 0.05, ∗∗P < 0.01 vs. control group; #P < 0.05, ##P < 0.01 vs. iopromide group.'
article_title: Salvianolic Acid B Attenuates Iopromide-Induced Renal Tubular Epithelial
  Cell Injury by Inhibiting the TLR4/NF-κB/NLRP3 Signaling Pathway.
citation: Ming Xin Pei, et al. Evid Based Complement Alternat Med. 2022;2022:8400496.
year: '2022'

doi: 10.1155/2022/8400496
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
